Huiran Lin

机构：Macau University of Science and Technology, Chinese Academy of Sciences, Shenzhen Institutes of Advanced Technology, Guangzhou Medical University

发表论文 42 篇 · 总被引 1106 次 · h-index 17

代表论文

• Functions, mechanisms, and therapeutic implications of METTL14 in human cancer (2022 · Journal of Hematology & Oncology · 被引 152)
• Role of N7-methylguanosine (m7G) in cancer (2022 · Trends in Cell Biology · 被引 78)
• PTBP2-Mediated Alternative Splicing of IRF9 Controls Tumor-Associated Monocyte/Macrophage Chemotaxis and Repolarization in Neuroblastoma Progression (2023 · Research · 被引 53)
• Variant rs8400 enhances ALKBH5 expression through disrupting miR-186 binding and promotes neuroblastoma progression (2023 · Chinese Journal of Cancer Research · 被引 52)
• Genetic variants in m6A modification core genes are associated with glioma risk in Chinese children (2021 · Molecular Therapy — Oncolytics · 被引 46)
• The role of m6A modification in pediatric cancer (2022 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 被引 39)